Healthcare Equipment and Supplies
Company Overview of Pulmonx Inc
Pulmonx Inc. engages in designing, developing, manufacturing, and marketing minimally-invasive medical devices and technologies for the diagnosis and treatment of pulmonary disorders. It offers Chartis Pulmonary Assessment System, which helps pulmonologists with lobe-specific information about a patient’s lung, and enables them to plan valve treatments to account for anatomical variations in the lungs of individual patients; and Zephyr Endobronchial Valve (EBV), a diagnostic and therapeutic solution to predict and achieve reduction of volume in the diseased portion of the lung without the risks and complications of surgery. The company’s products are used to deliver endoscopic lung volume re...
700 Chesapeake Drive
Redwood City, CA 94063
Founded in 1998
Key Executives for Pulmonx Inc
Chief Executive Officer, President and Director
Vice President of Finance and Administration
Executive Vice President and General Manager
Compensation as of Fiscal Year 2015.
Pulmonx Inc Key Developments
Pulmonx Announces the Lancet of Results from the BeLieVeR-HIFi clinical trial
Jul 1 15
Pulmonx announced the publication in the Lancet of results from the BeLieVeR-HIFi clinical trial. BeLieVeR-HIFi is a prospective, double-blind, randomized, sham-controlled trial comparing use of Pulmonx’s minimally invasive valve treatment for severe emphysema patients – the Zephyr Endobronchial Valve – to a sham bronchoscopy procedure. The study exceeded its primary endpoint, demonstrating a 20.9% average improvement in lung function (FEV1) in treated patients compared to control patients. Clinical and statistical significance on several secondary endpoints was also demonstrated, including exercise capacity and gas trapping. There was no statistical difference between groups in safety.
Pulmonx Corporation Announces Appointment of Glen French as President, Chief Executive Officer and Member of the Board of Directors
Dec 18 14
Pulmonx Corporation announced that appointment of Glen French as President, Chief Executive Officer and member of the Board of Directors. Most recently, he was CEO of ApniCure. Prior to ApniCure, Mr. French was Co-Founder, President and CEO of Asthmatx. At Asthmatx, he was responsible for guiding the company through clinical testing, FDA PMA approval, manufacturing expansion, initial product launch and acquisition by Boston Scientific Corporation. Following the acquisition, Mr. French served as President, Pulmonary Endoscopy for Boston Scientific's Endoscopy Division.
Similar Private Companies By Industry
Recent Private Companies Transactions
Most Searched Private Companies
Sponsored Financial Commentaries